Gamma Knife radiosurgery for cerebral cavernous malformation

Cheng‐Chia Lee, Wei-Hsin Wang, Huai‐Che Yang, Chung‐Jung Lin, Hsiu‐Mei Wu, Yen-Yu Lin, Yong-Sin Hu, Ching‐Jen Chen, Yuwei Chen, Chien-Chen Chou, Yo-Tsen Liu, Wen‐Yuh Chung, Cheng‐Ying Shiau, Wan‐Yuo Guo, David Hung‐Chi Pan, Sanford P.c. HsuScientific 2019 · DOI

TL;DR

This retrospective study demonstrates that Gamma Knife radiosurgery (GKS) significantly reduces the annual incidence of symptomatic hemorrhages in patients with cerebral cavernous malformations (CCMs). GKS emerges as a safe and effective alternative treatment for CCMs that are difficult to access surgically or for patients with significant medical comorbidities.

What Problem Does This Paper Address?

Cerebral cavernous malformations (CCMs) are vascular malformations in the brain that can lead to serious neurological issues, primarily through hemorrhage. While surgical resection is the definitive treatment, it carries significant risks, especially for CCMs located in deep or eloquent areas of the brain. For patients who are poor surgical candidates, or whose CCMs are surgically inaccessible, effective treatment options are limited. This paper addresses the need for a less invasive and effective treatment for symptomatic CCMs by evaluating the long-term efficacy and safety of Gamma Knife radiosurgery (GKS).

Methods

This study is a retrospective analysis of 261 patients with 331 symptomatic CCMs treated with GKS between 1993 and 2018. The treatment protocol involved using the Leksell Gamma Unit Model C, with prescription doses set at an isodose level of 50-90% and a median margin dose of 11.9 Gy. The researchers meticulously tracked patient outcomes, including the incidence of hemorrhages (both symptomatic and asymptomatic), seizure control, and adverse radiation effects (AREs). They calculated the annual incidence of hemorrhage before and after GKS to quantify its impact. Follow-up involved regular MRI scans and clinical evaluations.

Datasets

The study utilized a dataset of 261 patients with 331 symptomatic CCMs treated at Taipei Veterans General Hospital between 1993 and 2018. This dataset represents a longitudinal collection of clinical and imaging data, including pre-GKS hemorrhage history, GKS treatment parameters, and post-GKS follow-up data spanning up to 266 months.

Key Insights and Ideas

  • Significant Hemorrhage Reduction: The most striking finding is the dramatic decrease in the annual incidence of symptomatic hemorrhages after GKS, dropping from 23.6% pre-GKS to approximately 3.2% post-GKS. This highlights GKS's effectiveness in stabilizing these lesions.
  • Safety Profile: GKS demonstrated a favorable safety profile, with symptomatic radiation-induced complications occurring in only 3.1% of patients and a low mortality rate of 0.4%. This suggests GKS is a viable option for patients where surgical risks are high.
  • Seizure Control Potential: While not the primary focus, the study also noted improvements in seizure control for a significant portion of patients with epilepsy related to their CCMs, indicating a potential secondary benefit of GKS.
  • Alternative for Challenging Cases: The paper strongly advocates for GKS as a crucial alternative for patients with surgically inaccessible CCMs or those with significant comorbidities, expanding treatment options beyond observation or high-risk surgery.

Key Results

  • Hemorrhage Incidence:
    • Pre-GKS annual hemorrhage incidence: 23.6%
    • Post-GKS symptomatic hemorrhage incidence within 2 years: 3.22%
    • Post-GKS symptomatic hemorrhage incidence after 2 years: 3.16%
    • Overall post-GKS hemorrhage incidence (symptomatic and asymptomatic): 9.02% within 2 years, 7.52% beyond 2 years.
  • Adverse Radiation Effects (AREs): Symptomatic AREs occurred in 8 patients (3.1%).
  • Mortality: One patient (0.4%) died due to GKS-related complications.
  • Seizure Control: 78% of patients with seizures showed improvement after GKS.

Limitations and Future Work

The authors acknowledge that this is a retrospective study, which inherently has limitations compared to prospective, randomized controlled trials. While the study provides valuable long-term data, the exact radiobiological mechanisms by which GKS stabilizes CCMs remain an area for further investigation. Future research could focus on prospective studies to further validate these findings, explore optimal GKS parameters for different CCM locations and types, and investigate the long-term impact of GKS on asymptomatic hemorrhages. The paper also suggests that GKS may be particularly beneficial for eloquently located CCMs, warranting further focused studies in these specific patient populations.

Summary updated

Abstract

This is a retrospective study examining the efficacy and safety of Gamma Knife radiosurgery (GKS) in treating patients with cerebral cavernous malformations (CCMs). Between 1993 and 2018, 261 patients with 331 symptomatic CCMs were treated by GKS. The median age was 39.9 years and females were predominant (54%). The median volume of CCMs was 3.1 mL. The median margin dose was 11.9 Gy treat to a median isodose level of 59%. Median clinical and imaging follow-up times were 69 and 61 months, respectively. After the initial hemorrhage that led to CCM diagnosis, 136 hemorrhages occurred in the period prior to GKS (annual incidence = 23.6%). After GKS, 15 symptomatic hemorrhages occurred within the first 2 years of follow-up (annual incidence = 3.22%), and 37 symptomatic hemorrhages occurred after the first 2 years of follow-up (annual incidence = 3.16%). Symptomatic radiation-induced complication was encountered in 8 patients (3.1%). Mortality related to GKS occurred in 1 patient (0.4%). In conclusion, GKS decreased the risk of hemorrhage in CCM patients presenting with symptomatic hemorrhage. GKS is a viable alternative treatment option for patients with surgically-inaccessible CCMs or significant medical comorbidities.
BibTeX
@inproceedings{lee2019gamma,
  author = {Cheng‐Chia Lee and Wei-Hsin Wang and Huai‐Che Yang and Chung‐Jung Lin and Hsiu‐Mei Wu and Yen-Yu Lin and Yong-Sin Hu and Ching‐Jen Chen and Yuwei Chen and Chien-Chen Chou and Yo-Tsen Liu and Wen‐Yuh Chung and Cheng‐Ying Shiau and Wan‐Yuo Guo and David Hung‐Chi Pan and Sanford P.C. Hsu},
  title = {{Gamma Knife radiosurgery for cerebral cavernous malformation}},
  booktitle = {Scientific},
  year = {2019},
  doi = {10.1038/s41598-019-56119-1},
}
Figure